Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3491Neoplasms 2738Prostatic Neoplasms 1580Colorectal Neoplasms 1243Lung Neoplasms 1184Motor Activity 763Head and Neck Neoplasms 619Pancreatic Neoplasms 600Colonic Neoplasms 586Uterine Cervical Neoplasms 563Carcinoma, Non-Small-Cell Lung 559Carcinoma, Hepatocellular 556Rectal Neoplasms 514Stomach Neoplasms 490Brain Neoplasms 435Anxiety Disorders 400Ovarian Neoplasms 396Pain 375Esophageal Neoplasms 347Neoplasm Metastasis 340Polycystic Ovary Syndrome 339Fatigue 323Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 285Multiple Myeloma 281Endometrial Neoplasms 262Lymphoma 257Hematologic Neoplasms 250

Interventions

Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER × Mixed Tumor, Mesodermal × Clear all
NCT01737619 2026-05-04

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
101 enrolled 8 charts

Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡